Department of Psychiatry, Leiden University Medical Center, The Netherlands
Kuan-Yu Pan
Department of Psychiatry, Amsterdam Public Health, Amsterdam University Medical Center, Vrije Universiteit, The Netherlands; and Department of Psychiatry, Geestelijke Gezondheidszorg (GGZ) InGeest, The Netherlands
Department of Psychiatry, Amsterdam Public Health, Amsterdam University Medical Center, Vrije Universiteit, The Netherlands; and Department of Psychiatry, GGZ InGeest, The Netherlands
Frederike Jörg
University Center for Psychiatry, University Medical Center Groningen, The Netherlands; and Research Department, GGZ Friesland, The Netherlands
Merijn Eikelenboom
Department of Psychiatry, Amsterdam Public Health, Amsterdam University Medical Center, Vrije Universiteit, The Netherlands; and Department of Psychiatry, GGZ InGeest, The Netherlands
Melany Horsfall
Department of Psychiatry, Amsterdam Public Health, Amsterdam University Medical Center, Vrije Universiteit, The Netherlands; and Department of Psychiatry, GGZ InGeest, The Netherlands
Rob A. Luteijn
Department of Psychiatry, Amsterdam Public Health, Amsterdam University Medical Center, Vrije Universiteit, The Netherlands; and Department of Psychiatry, GGZ InGeest, The Netherlands
Patricia van Oppen
Department of Psychiatry, Amsterdam Public Health, Amsterdam University Medical Center, Vrije Universiteit, The Netherlands; and Department of Psychiatry, GGZ InGeest, The Netherlands
Didi Rhebergen
Department of Psychiatry, Amsterdam Public Health, Amsterdam University Medical Center, Vrije Universiteit, The Netherlands; Department of Psychiatry, GGZ InGeest, The Netherlands; and Mental Health Care Institute, GGZ Centraal, The Netherlands
University Center for Psychiatry, University Medical Center Groningen, The Netherlands
Brenda W. J. H. Penninx
Department of Psychiatry, Amsterdam Public Health, Amsterdam University Medical Center, Vrije Universiteit, The Netherlands; and Department of Psychiatry, GGZ InGeest, The Netherlands
Erik J. Giltay
Department of Psychiatry, Leiden University Medical Center, The Netherlands
Background Mental health was only modestly affected in adults during the early months of the COVID-19 pandemic on the group level, but interpersonal variation was large. Aims We aim to investigate potential predictors of the differences in changes in mental health. Method Data were aggregated from three Dutch ongoing prospective cohorts with similar methodology for data collection. We included participants with pre-pandemic data gathered during 2006–2016, and who completed online questionnaires at least once during lockdown in The Netherlands between 1 April and 15 May 2020. Sociodemographic, clinical (number of mental health disorders and personality factors) and COVID-19-related variables were analysed as predictors of relative changes in four mental health outcomes (depressive symptoms, anxiety and worry symptoms, and loneliness), using multivariate linear regression analyses. Results We included 1517 participants with (n = 1181) and without (n = 336) mental health disorders. Mean age was 56.1 years (s.d. 13.2), and 64.3% were women. Higher neuroticism predicted increases in all four mental health outcomes, especially for worry (β = 0.172, P = 0.003). Living alone and female gender predicted increases in depressive symptoms and loneliness (β = 0.05–0.08), whereas quarantine and strict adherence with COVID-19 restrictions predicted increases in anxiety and worry symptoms (β = 0.07–0.11).Teleworking predicted a decrease in anxiety symptoms (β = −0.07) and higher age predicted a decrease in anxiety (β = −0.08) and worry symptoms (β = −0.10). Conclusions Our study showed neuroticism as a robust predictor of adverse changes in mental health, and identified additional sociodemographic and COVID-19-related predictors that explain longitudinal variability in mental health during the COVID-19 pandemic.